A new study has found that combining ibrutinib and rituximab could help cancer patients with chronic lymphocytic leukemia (CLL). The results of the study were presented this week at the 54th annual meeting of the American Society of Hematology (ASH). …

According to new research, Chemotherapy can induce changes in patient brains, affecting their concentration and memory. Dubbed “chemo brain,” the physiological effects were detected by researchers using PET/CT scans. “The chemo brain phenomenon is described as ‘mental fog’ and ‘loss …

A study by the Group Health Research Institute in Seattle has determined that trastuzumab, the drug behind the brand name Herceptin, raises the risks for heart problems in breast cancer patients much more than previously thought. Trastuzumab is widely prescribed …